Embryonal rhabdomyosarcoma of the uterine corpus in a 76-year-old patient

Gynecologic Oncology

Volumn 75, Issue 3, 1999, Pages 490-494

  Takano, Masashi ^a   Kikuchi, Yoshihiro ^a   Aida, Shinsuke ^a   Sato, Kimiya ^a   Nagata, Ichiro ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ABDOMINAL HYSTERECTOMY; ABDOMINAL MASS; AGED; ARTICLE; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; EMBRYONAL RHABDOMYOSARCOMA; FEMALE; HUMAN; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; SALPINGOOOPHORECTOMY; TREATMENT OUTCOME; UTERUS SARCOMA;

EID: 0032801368     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5593     Document Type: Article

References (11)

1. Gaiger A M, Soule E M, Newton W A. Pathology of rhabdomyosarcoma: experience of the Intergroup Rhabdomyosarcoma Study, 1972-78. Natl Cancer Inst Monogr. 56:1981;19-27.
2. Lloyd R V, Hajdu S I, Knapper W H. Embryonal rhabdomyosarcoma in adults. Cancer. 51:1983;557-565.
3. Hahlin M, Jaworski R C, Wain G V, Harnett P R, Neesham D, Bull C. Integrated multimodality therapy for embryonal rhabdomyosarcoma of the lower genital tract in postpubertal females. Gynecol Oncol. 70:1998;141-146.
4. Kempson R L, Bari W. Uterine sarcomas: classification, diagnosis, and prognosis. Hum Pathol. 1:1970;331-349.
5. Ober W B, Tovell H MM. Mesenchymal sarcomas of the uterus. Am J Obstet Gynecol. 77:1959;246-268.
6. Hart W R, Craig J R. Rhabdomyosarcomas of the uterus. Am J Clin Pathol. 70:1978;217-223.
7. Hays D M, Shimada H, Raney R B Jr, Tefft M, Newton W, Crist W M, Lawrence W Jr, Ragag A, Beltangady M, Maurer H M. Clinical staging and treatment results in rhabdomyosarcoma of the female genital tract among children and adolescents. Cancer. 61:1988;1893-1903.
8. Thomas W M, Gerrit D, John B S, Otis G Jr, Paul M. Embryonal rhabdomyosarcoma of the uterine corpus and cervix. Gynecol Oncol. 25:1986;171-194.
9. Maurer H M, Moon T, Donaldson M, Fernandez C, Gehan E A, Hammond D, Hays D M, Lawrence W Jr, Newton W, Ragab A, Raney B, Soule E H, Sutow W W, Tefft M. The intergroup rhabdomyosarcoma study. A preliminary report. Cancer. 40:1977;2015-2026.
10. Mukai K, Robai I, Hallaway B E. Localization of myoglobin in normal and neoplastic human skeletal muscle cells using an immunoperoxidase method. Am J Surg Pathol. 3:1979;373-376.
11. Santoro A, Tursz T, Mouridsen H, Verweij J, Steward W, Somers R, Buesa J, Casali P, Spooner D, Rankin E, Kirkpatrick A, Glabbeke M V, van Oostrom A. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol. 13:1995;1537-1545.